Pharmacolog Inc. has received an order for WasteLog® from Bronson Methodist Hopital Kalamazoo, Michigan. The system will be used to control the return of narcotics at the healthcare groups main trauma center.
Bronson Methodist Hospital is a 434-bed teaching hospital and trauma center located in central Kalamazoo, Michigan. Bronson Methodist Hospital is the flagship of the Bronson Healthcare Group, a nonprofit healthcare system with a total of four hospitals located in southwest Michigan and northern Indiana.
After evaluation, Bronson Methodist Hopital decided to invest in WasteLog as the main solution for the control of returned narcotic drugs, a WasteLog® system to be placed at their main trauma center. The use of WasteLog® is part of the Bronson Drug Diversion Prevention program. The agreement is a direct sale via Pharmacolog USA Inc. and has an order value of aprox. SEK 400 000.
Director of Sales North American Market, Jeffrey Marton comments: “Working with Bronson Methodist Hospital has been an excellent experience. A five-minute meeting with the hospital turned into a virtual demo and then a month later a live demo of WasteLog. The pharmacy team was very impressed with the accuracy, technology, portability, time saving capabilities, and the cost effectiveness. We beat our competition again as we continue to grow in the North American Market.“
CEO, Mats Högberg comments: “It is very gratifying that Bronson Methodist Hospital chooses WasteLog® as a solution for waste screening. Bronson Medical consists of a large number of healthcare facilities and our hope is that WasteLog will also be introduced at several of the group's hospitals and surgical centers.”
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on June 21st, 2021 at 17:00.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.